SCHEMBL26962003

SCHEMBL26962003

NNC(=O)[C@H]1CCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.67
NPC1 O15118 2/20 0.67
RAB9A P51151 2/20 0.67
CYP2C19 P33261 1/20 0.67
HTT P42858 1/20 0.60
ENPP2 Q13822 1/20 0.54
GRIN2B Q13224 9/20 0.54
CYP2D6 P10635 4/20 0.53
CYP2C9 P11712 4/20 0.53
CYP3A4 P08684 3/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAPT P10636 1/20 0.48
USP30 Q70CQ3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26962235 1.00 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL2712060 0.92 SMN1; SMN2 (0.77) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL29797014 0.90 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL830296 0.90 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL6473595 0.86 HTT (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL15084818 0.86 HTT (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL15084666 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL12071947 0.86 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL5350590 0.86 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL12070966 0.85 SMN1; SMN2 (0.84) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 EP disclosed
WO-2022171745-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2022-08-18 WO disclosed